Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis.

Bewley A, Fowler J, Schöfer H, Kerrouche N, Rives V.

Dermatol Ther (Heidelb). 2016 Jun;6(2):237-47. doi: 10.1007/s13555-016-0106-9. Epub 2016 Mar 16. Erratum in: Dermatol Ther (Heidelb). 2016 Jun;6(2):249.

2.

Development and Evaluation of a Rosacea Screening Instrument (Rosascreen).

Tan J, Leyden J, Cribier B, Audibert F, Kerrouche N, Berg M; RISG Committee.

J Cutan Med Surg. 2016 Jul;20(4):317-22. doi: 10.1177/1203475416629118. Epub 2016 Feb 1.

3.

Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea.

Raedler LA.

Am Health Drug Benefits. 2015 Mar;8(Spec Feature):122-5. No abstract available.

4.

The role of brimonidine tartrate gel in the treatment of rosacea.

Jackson JM, Knuckles M, Minni JP, Johnson SM, Belasco KT.

Clin Cosmet Investig Dermatol. 2015 Oct 23;8:529-38. doi: 10.2147/CCID.S58920. eCollection 2015. Review.

5.

The use of facial modeling and analysis to objectively quantify facial redness.

Foolad N, Prakash N, Shi VY, Kamangar F, Wang Q, Li CS, Sivamani RK.

J Cosmet Dermatol. 2016 Mar;15(1):43-8. doi: 10.1111/jocd.12191. Epub 2015 Nov 4.

PMID:
26534767
6.

Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies.

Holmes AD, Waite KA, Chen MC, Palaniswamy K, Wiser TH, Draelos ZD, Rafal ES, Werschler WP, Harvey AE.

J Clin Aesthet Dermatol. 2015 Aug;8(8):29-35. Review.

7.

Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients.

Metzler-Wilson K, Toma K, Sammons DL, Mann S, Jurovcik AJ, Demidova O, Wilson TE.

J Neurophysiol. 2015 Sep;114(3):1530-7. doi: 10.1152/jn.00458.2015. Epub 2015 Jul 1.

PMID:
26133800
8.

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea.

Johnson AW, Johnson SM.

Dermatol Ther (Heidelb). 2015 Sep;5(3):171-81. doi: 10.1007/s13555-015-0078-1. Epub 2015 Jun 26.

9.

Update on the management of rosacea.

Weinkle AP, Doktor V, Emer J.

Clin Cosmet Investig Dermatol. 2015 Apr 7;8:159-77. doi: 10.2147/CCID.S58940. eCollection 2015.

10.

Combination surgical excision and fractional carbon dioxide laser for treatment of rhinophyma.

Kassir R, Gilbreath J, Sajjadian A.

World J Plast Surg. 2012 Jan;1(1):36-40.

11.

Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea.

Gravina A, Federico A, Ruocco E, Lo Schiavo A, Masarone M, Tuccillo C, Peccerillo F, Miranda A, Romano L, de Sio C, de Sio I, Persico M, Ruocco V, Riegler G, Loguercio C, Romano M.

United European Gastroenterol J. 2015 Feb;3(1):17-24. doi: 10.1177/2050640614559262.

12.

Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.

Kim JY, Kim YJ, Lim BJ, Sohn HJ, Shin D, Oh SH.

Yonsei Med J. 2014 Nov;55(6):1648-55. doi: 10.3349/ymj.2014.55.6.1648.

13.

Unusual features of rosacea in saudi females with dark skin.

Al Balbeesi AO, Halawani MR.

Ochsner J. 2014 Fall;14(3):321-7.

14.

Recent advances in the understanding and management of rosacea.

Wollina U.

F1000Prime Rep. 2014 Jul 8;6:50. doi: 10.12703/P6-50. eCollection 2014. Review.

15.

The efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and age.

Lim HS, Lee SC, Won YH, Lee JB.

Ann Dermatol. 2014 Aug;26(4):491-5. doi: 10.5021/ad.2014.26.4.491. Epub 2014 Jul 31.

16.

High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 study.

Sinikumpu SP, Huilaja L, Jokelainen J, Koiranen M, Auvinen J, Hägg PM, Wikström E, Timonen M, Tasanen K.

PLoS One. 2014 Jun 9;9(6):e99533. doi: 10.1371/journal.pone.0099533. eCollection 2014.

18.

Oxymetazoline (topical): rosacea.

Generali JA, Cada DJ.

Hosp Pharm. 2013 Jul;48(7):558-9. doi: 10.1310/hpj4807-558.

19.

Effects of a facial cream containing the minor alkaloid anatabine on improving the appearance of the skin in mild to moderate rosacea: an open-label case series study.

Lanier RK, Cohen AE, Weinkle SH.

Case Rep Dermatol. 2013 Nov 23;5(3):347-56. doi: 10.1159/000357019. eCollection 2013.

20.

Antinuclear antibodies in rosacea patients.

Woźniacka A, Salamon M, McCauliffe D, Sysa-Jędrzejowska A.

Postepy Dermatol Alergol. 2013 Feb;30(1):1-5. doi: 10.5114/pdia.2013.33372. Epub 2013 Feb 20.

Items per page

Supplemental Content

Write to the Help Desk